Skip to main content
Clinical Trials/NL-OMON44074
NL-OMON44074
Completed
N/A

Cognitive Remediation Therapy (CRT) as a treatment enhancer in eating disorders and obsessive compulsive disorders - Cognitive Remediation Therapy in eating disorders and OCD

Altrecht GGZ (Den Dolder)0 sites192 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
én obssesieve compulsieve stoornissen
Sponsor
Altrecht GGZ (Den Dolder)
Enrollment
192
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Altrecht GGZ (Den Dolder)

Eligibility Criteria

Inclusion Criteria

  • ED patients: The ED patients encompass primarily patients with Anorexia nervosa (including those patients that meet some but not all of the diagnostic criteria for AN who are diagnosed as Eating Disorders Not Otherwise Specified ( (clinically referred to as AN) as established by medical experts and verified with the Structured Clinical Interview on axis I DSM V diagnoses (SCID\-I; for a structural diagnosis)/ assessed with the aid of the Eating Disorder Examination Interview.;OCD patients: The OCD patients encompass OCD patients of all symptom dimensions (Leckman, Grice, Boardman et al., 1997\), as established by medical experts and verified with the Structured Clinical Interview on axis I DSM IV diagnoses (SCID\-I; for a structural diagnosis) and should have a Yale\- Brown Obsessive\-compulsive scale (Goodman, Price, Rasmussen et al., 1989a,1989b) severity score of \> 16\.;Control participants: The control participants encompass only adult people of whom 50% is matched to the ED patient group and 50%.to the OCD patient group regarding gender and age

Exclusion Criteria

  • Patients with neurological illness (epilepsia, Parkinson\*s disease), co\-morbid severe psychiatric disorders (severe major depressive disorder, current psychosis, dependence and abuse of alcohol, drugs), mental deficiency (IQ \< 80\) and inability to adequately read or speak Dutch will be excluded. Use of anti\-depressants will be permitted, provided that dosages are kept constant during the experimental part of the study. Benzodiazepine use will be accepted only when used as sleep medication, since benzodiazepine use might hamper the effect of cognitive treatments.
  • Control participants with a current episode or history of psychiatric disorders as determined with the MINI interview, with neurological illness, mental deficiency, or an inability to adequately read of speak Dutch will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials